Immunodepleting Aβ from brains of rTg9191, Tg2576 mice, and AD patients decreased OC immunoreactivity to a level comparable to that of the non-transgenic brains, indicating that OC-immunoreactive signals come from soluble Aβ oligomers. This evidence concerns the gene BGLAP and Alzheimer disease.